Elevated homocysteine levels in patients with slow coronary flow:: Relationship with Helicobacter pylori infection

被引:36
作者
Evrengul, Harun
Tanriverdi, Halil
Kuru, Omur
Enli, Yasar
Yuksel, Dogangun
Kilic, Ayhan
Kaftan, Asuman
Kirac, Suna
Kilic, Mustafa
机构
[1] Pamukkale Univ, Sch Med, Dept Cardiol, Denizli, Turkey
[2] Pamukkale Univ, Sch Med, Dept Biochem, Denizli, Turkey
[3] Pamukkale Univ, Sch Med, Dept Nucl Med, Denizli, Turkey
[4] Gulhane Mil Med Acad, Dept Pediat Cardiol, Ankara, Turkey
关键词
slow coronary flow; Helicobacter pylori; homocysteine; ISCHEMIC-HEART-DISEASE; ARTERY-DISEASE; PLASMA HOMOCYSTEINE; RISK-FACTOR; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; SYSTEMIC INFLAMMATION; VASCULAR-DISEASE; ANGINA-PECTORIS; FOLIC-ACID;
D O I
10.1111/j.1523-5378.2007.00505.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and objective: Elevation of plasma homocysteine (Hcy) level has been implicated in the pathogenesis of slow coronary flow (SCF) as it can severely disturb vascular endothelial function. Helicobacter pylori chronically infect the human stomach and causes malabsorption of vitamin B-12 and folate leading ultimately to an increase in circulating Hcy levels. in food, Methods: Forty-three patients with angiographically proven SCF (group I) were enrolled in this study; 43 cases with normal coronary flow pattern (group II) served as controls. Fasting plasma levels of Hcy, vitamin B,,, and folate were measured in all subjects. Presence of H. pylori infection was defined as positive 14 C urea breath test. Coronary flow patterns for each major epicardial coronary artery were determined with the Thrombolysis in Myocardial infarction (TIMI) frame count method. Results: Mean TIMI frame count was 46.3 +/- 8.7 in group I and 24.3 +/- 2.9 in Group II (p =.0001). Vitamin (12), levels were similar, whereas folate levels were dramatically reduced in group I compared to group II (13.2 +/- 4.3 vs. 17.1 +/- 5.2, p =.0001). Plasma Hcy levels were significantly higher in group I compared to group II (13.4 +/- 5.6 vs. 7.9 +/- 2.5, p =.000 1) as was the prevalence of H. pylori infection (90.7% in group I vs. 58.1 % in group II, p =.001). Hcy levels were elevated (11.7 +/- 5.3 vs. 7.5 +/- 2.7, p =.0001) and folate levels were reduced (13.9 +/- 4.7 vs. 18.6 +/- 4.9, p.0001) in patients with H. pylori infection, while vitamin B, levels were similar in patients with and without H. pylori infection. Correlation analysis revealed a significant negative correlation between plasma folate and Hcy levels and also between folate levels and mean TIMI frame counts (r = -.33, p =.002 vs. r = -.33, p =.003). Moreover, there was a significant positive correlation between plasma Hcy levels and mean TIMI frame counts (r =.66, p =.0001). In addition, the folate level was the only significant determinant of the variance of Hcy in multiple regression analysis (r = -21, p =.03). Conclusion: Our data showed that plasma folate levels were decreased and plasma Hcy levels were increased in patients with SCF compared to controls. Also, the prevalence of H. pylori infection was increased in patients with SCF. These findings suggest that elevated levels of plasma Hcy, possibly caused by H. pylori infection, and/or a possible disturbance in its metabolism may play a role in the pathogenesis of SCF.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 50 条
[1]   Elevated plasma homocysteine level in slow coronary flow [J].
Barutcu, I ;
Sezgin, AT ;
Sezgin, N ;
Gullu, H ;
Esen, AM ;
Topal, E ;
Ozdemir, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 101 (01) :143-145
[2]   HELICOBACTER-PYLORI - ITS ROLE IN DISEASE [J].
BLASER, MJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :386-393
[3]   Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults:: results from a large population-based study [J].
Brenner, H ;
Berg, G ;
Fröhlich, M ;
Boeing, H ;
Koenig, W .
ATHEROSCLEROSIS, 1999, 147 (02) :399-403
[4]   Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow [J].
Çamsari, A ;
Pekdemir, H ;
Çiçek, D ;
Polat, G ;
Akkus, MN ;
Döven, O ;
Cin, G ;
Katircibasi, T ;
Parmaksiz, T .
CIRCULATION JOURNAL, 2003, 67 (12) :1022-1028
[5]   Elevated level of plasma homocysteine in patients with slow coronary flow [J].
Erbay, AR ;
Turhan, H ;
Yasar, AS ;
Ayaz, S ;
Sahin, O ;
Senen, K ;
Sasmaz, H ;
Yetkin, E .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (03) :419-423
[6]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[7]   TIMI frame count: A quantitative method of assessing coronary artery flow [J].
Gibson, CM ;
Cannon, CP ;
Daley, WL ;
Dodge, JT ;
Alexander, B ;
Marble, SJ ;
McCabe, CH ;
Raymond, L ;
Fortin, T ;
Poole, WK ;
Braunwald, E .
CIRCULATION, 1996, 93 (05) :879-888
[8]   Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice [J].
Gomollón, F ;
Ducons, JA ;
Santolaria, S ;
Omiste, IL ;
Guirao, R ;
Ferrero, A ;
Montoro, M .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :612-618
[9]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[10]  
HEINECKE JW, 1993, J LIPID RES, V34, P2051